Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOSIS: ICS Down-titration in Severe Asthma
NCT03321877Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Oct 2016
- Primary completion
- May 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial in asthma, sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Responsiveness to methacholine bronchial challenge at 8 weeks. Started Oct 2016; status: completed.
02
Conditions
asthma
Beyond the preview
Go deeper on NCT03321877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321877.